Login / Signup
Maria Maddalena Tumedei
ResearcherID
ORCID
Publication Activity (10 Years)
Years Active: 2020-2022
Publications (10 Years): 2
Top Topics
Adverse Drug
Cancer Therapy
Ejection Fraction
Peritoneal Dialysis
Top Venues
Cancer immunology, immunotherapy : CII
Expert opinion on therapeutic targets
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Michela Cortesi
,
Michele Zanoni
,
Roberta Maltoni
,
Sara Ravaioli
,
Maria Maddalena Tumedei
,
Francesca Pirini
,
Sara Bravaccini
TROP2 (trophoblast cell-surface antigen 2): a drug target for breast cancer.
Expert opinion on therapeutic targets
26 (7) (2022)
Sara Ravaioli
,
Francesco Limarzi
,
Maria Maddalena Tumedei
,
Michela Palleschi
,
Roberta Maltoni
,
Sara Bravaccini
Are we ready to use TMB in breast cancer clinical practice?
Cancer immunology, immunotherapy : CII
69 (10) (2020)